Prognostic Value of an Immune Long Non-Coding RNA Signature in Liver Hepatocellular Carcinoma

키워드

참고문헌 (61)

1. Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J. Clin, 71, pp.209~249 (2021)
2. Takayama T, "Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma : a randomised trial", Lancet, 356, pp.802~807 (2000)
3. Dimitroulis D, "From diagnosis to treatment of hepatocellular carcinoma : an epidemic problem for both developed and developing world", World J. Gastroenterol, 23, pp.5282~5294 (2017)
4. Bruix J, "Management of hepatocellular carcinoma : an update", Hepatology, 53, pp.1020~1022 (2011)
5. Forner A, "Hepatocellular carcinoma", Lancet, 391, pp.1301~1314 (2018)
6. Sangro B, "Advances in immunotherapy for hepatocellular carcinoma", Nat. Rev. Gastroenterol. Hepatol, 18, pp.525~543 (2021)
7. Kairaluoma V, "Toll-like receptor 5 and 8 in hepatocellular carcinoma", APMIS, 129, pp.470~479 (2021)
8. Pinna F, "A20", TNFAIP3 discriminates tumor necrosis factor (TNF)-induced NF-kappaB from JNK pathway activation in hepatocytes, 2017, pp.8, 610~
9. Pfister D, "NASH limits anti-tumour surveillance in immunotherapy-treated HCC", Nature, 592, pp.450~456 (2021)
10. Ruf B, "Immunobiology and immunotherapy of HCC : spotlight on innate and innate-like immune cells", Cell Mol. Immunol, 18, pp.112~127 (2021)
11. Rosenberg SA, "Adoptive cell transfer as personalized immunotherapy for human cancer", Science, 348, pp.62~68 (2015)
12. Huang ZM, "Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma", J. Cancer Res. Ther, 16, pp.1603~1610 (2020)
13. Ringelhan M, "The immunology of hepatocellular carcinoma", Nat. Immunol, 19, pp.222~232 (2018)
14. Kim HJ, "Clinical significance of soluble programmed cell death ligand-1(sPD-L1)in hepatocellular carcinoma patients treated with radiotherapy", Radiother. Oncol, 129, pp.130~135 (2018)
15. Long J, "Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma", Ebiomedicine, 42, pp.363~374 (2019)
16. Zhang J, "The long-noncoding RNA MALAT1 regulates TGF-beta", Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells, 2020, pp.15, e228160~
17. Djebali S, "Landscape of transcription in human cells", Nature, 489, pp.101~108 (2012)
18. Derrien T, "The GENCODE v7 catalog of human long noncoding RNAs : analysis of their gene structure, evolution, and expression", Genome Res, 22, pp.1775~1789 (2012)
19. Lv X, "FAL1 : a critical oncogenic long non-coding RNA in human cancers", Life Sci, 236, pp.116918~ (2019)
20. Holoch D, "RNA-mediated epigenetic regulation of gene expression", Nat. Rev. Genet, 16, pp.71~84 (2015)
21. Wang YL, "Lnc-UCID promotes G1", S transition and hepatoma growth by preventing DHX9-mediated CDK6 down-regulation, 2019, pp.70, 259~275
22. Lin C, "Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p", CDK6 axis, 2020, pp.76, 469~481
23. Song P, "Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer", Clin. Epigenetics, 14, pp.138~ (2022)
24. Wang C, "RNA sequencing analyses of gene expression during epstein-barr virus infection of primary B lymphocytes", J. Virol, 93, pp.e00226-19~ (2019)
25. Unfried JP, "Long noncoding RNA IHCOLE promotes ligation efficiency of DNA double-strand breaks in hepatocellular carcinoma", Cancer Res, 81, pp.4910~4925 (2021)
26. Peng WX, "LncRNA-mediated regulation of cell signaling in cancer", Oncogene, 36, pp.5661~5667 (2017)
27. Su W, "LncRNA MIR22HG abrogation inhibits proliferation and induces apoptosis in esophageal adenocarcinoma cells via activation of the STAT3", c-Myc, Aging(Albany NY), pp.2019, 11[DOI]
28. Wang BG, "The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis", Gene, 670, pp.148~154 (2018)
29. Wang Y, "The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186", J. Biol. Chem, 292, pp.15395~15407 (2017)
30. Zhang J, "A transforming growth factor-beta and H19 signaling axis in tumor-initiating hepatocytes that regulates hepatic carcinogenesis", Hepatology, 69, pp.1549~1563 (2019)
31. "The Cancer genome atlas"[URL]
32. "Ensemble website"[URL]
33. "Gene Set Enrichment Analysis"[URL]
34. Shannon P, "Cytoscape : a software environment for integrated models of biomolecular interaction networks", Genome Res, 13, pp.2498~2504 (2003)
35. Wang C, "Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types", Nat. Commun, 7, pp.10499~ (2016)
36. Li S, "Exosomal long noncoding RNA lnc-GNAQ-6 : 1 may serve as a diagnostic marker for gastric cancer", Clin. Chim. Acta, 501, pp.252~257 (2019)
37. Chao P, "lncRNA HOTAIR knockdown suppresses gastric cancer cell biological activities", Food Sci. Nutr, 9, pp.123~134 (2021)
38. Vishnubalaji R, "Noncoding RNAs as potential mediators of resistance to cancer immunotherapy", Semin. Cancer Biol, 35, pp.65~79 (2019)
39. DiStefano JK, "Long noncoding RNAs in the initiation, progression, and metastasis of hepatocellular carcinoma", Noncoding RNA Res, 2, pp.129~136 (2017)
40. Ni W, "A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1", J. Hematol. Oncol, 10, pp.91~ (2017)
41. Zhang D, "Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K", Akt pathways, 2017, pp.85, 511~516
42. Jiang R, "The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion", Nat. Commun, 8, pp.15129~ (2017)
43. Liu X, "PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma", Cancer Immunol. Immunother, 68, pp.2041~2054 (2019)
44. McLane LM, "CD8 T cell exhaustion during chronic viral infection and cancer", Annu. Rev. Immunol, 37, pp.457~495 (2019)
45. Matos LL, "External validation of the AJCC Cancer Staging Manual, 8th edition, in an independent cohort of oral cancer patients", Oral Oncol, 71, pp.47~53 (2017)
46. Zhou P, "Construction of an immune-related six-lncRNA signature to predict the outcomes, immune cell infiltration, and immunotherapy response in patients with hepatocellular carcinoma", Front. Oncol, 11, pp.661758~ (2021)
47. Gao C, "Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma", Front. Genet, 13, pp.956094~ (2022)
48. Zhou J, "Prediction of prognosis and chemotherapeutic sensitivity based on cuproptosisassociated lncRNAs in cervical squamous cell carcinoma and endocervical adenocarcinoma", Genes (Basel), 14, pp.1481~ (2023)
49. Zhong F, "LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11", PI3K, J. Cancer, pp.2022, 13[DOI]
50. Bird TG, "Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection", PLoS One, 11, pp.e156801~ (2016)
51. Johnson P, "Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma", Nat. Rev. Gastroenterol. Hepatol, 19, pp.670~681 (2022)
52. Tzartzeva K, "Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis", Gastroenterology, 154, pp.1706~1718 (2018)
53. Galle PR, "Biology and significance of alpha-fetoprotein in hepatocellular carcinoma", Liver Int, 39, pp.2214~2229 (2019)
54. Van Hees S, "Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma", World J. Gastroenterol, 22, pp.8271~8282 (2016)
55. Sterling RK, "Frequency of elevated hepatocellular carcinoma(HCC)biomarkers in patients with advanced hepatitis C", Am. J. Gastroenrol, 107, pp.64~74 (2012)
56. Bennett CL, "Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients", Aacta Neuropathol, 136, pp.425~443 (2018)
57. Wymer KM, "Mildly elevated serum alpha-fetoprotein(AFP)among patients with testicular cancer may not be associated with residual cancer or need for treatment", Ann. Oncol, 28, pp.899~902 (2017)
58. Sun W, "Regulatory mechanisms of long noncoding RNAs on gene expression in cancers", Cancer Genet, 216-217, pp.105~110 (2017)
59. Huang D, "NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death", Nat. Immunol, 19, pp.1112~1125 (2018)
60. Wu W, "LncRNA NKILA suppresses TGF-beta-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer", Int. J. Cancer, 143, pp.2213~2224 (2018)
61. Zhou Y, "LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8", ID2pathway in hepatocellular carcinoma, 2019, pp.469, 399~409

관련 논문AI추천